Correspondence

You have full text access to this OnlineOpen article

Need for a three-focused approach to nonalcoholic fatty liver disease†

  1. Giovanni Musso M.D.1,
  2. Roberto Gambino Ph.D.2,
  3. Maurizio Cassader Ph.D.2

Article first published online: 22 APR 2011

DOI: 10.1002/hep.24070

Issue

Hepatology

Hepatology

Volume 53, Issue 5, page 1773, May 2011

Additional Information

How to Cite

Musso, G., Gambino, R. and Cassader, M. (2011), Need for a three-focused approach to nonalcoholic fatty liver disease. Hepatology, 53: 1773. doi: 10.1002/hep.24070

Author Information

  1. 1

    Gradenigo Hospital, Turin, Italy

  2. 2

    Department of Internal Medicine University of Turin, Turin, Italy

  1. †

    Potential conflict of interest: Nothing to report.

Publication History

  1. Issue published online: 22 APR 2011
  2. Article first published online: 22 APR 2011
  3. Accepted manuscript online: 12 NOV 2010 02:01PM EST
  4. Manuscript Accepted: 29 OCT 2011

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (296K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    G. Musso, M. Cassader, F. Rosina, R. Gambino, Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials, Diabetologia, 2012, 55, 4, 885

    CrossRef

  2. 2
    Giovanni Musso, Maurizio Cassader, Franco De Michieli, Floriano Rosina, Fabio Orlandi, Roberto Gambino, Nonalcoholic steatohepatitis versus steatosis: Adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism , Hepatology, 2012, 56, 3
    Direct Link:
  3. 3
    Giovanni Musso, The Finnish Diabetes Risk Score (FINDRISC) and other non-invasive scores for screening of hepatic steatosis and associated cardiometabolic risk, Annals of Medicine, 2011, 43, 6, 413

    CrossRef

  4. 4
    Giovanni Musso, Federica Molinaro, Elena Paschetta, Roberto Gambino, Maurizio Cassader, Lipid Modifiers and NASH: Statins, Ezetimibe, Fibrates, and Other Agents,
    Direct Link:
View Full Article (HTML) Get PDF (296K)